[Federal Register Volume 67, Number 115 (Friday, June 14, 2002)]
[Notices]
[Pages 40930-40931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 02-15014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30DAY-34-02]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503. Written
comments should be received within 30 days of this notice.
Proposed Project: The Development and Testing of a Tool to Assess
the Public's Perception about People with
[[Page 40931]]
Epilepsy--New--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC). About 2.3 million people in the U.S. have some form of epilepsy,
a neurological condition in which the brain's normal electrical
functions may be interrupted with bursts of electrical impulses.
Epilepsy affects people of all ages, but particularly the very young
and the elderly. Persons with chronic or disabling health conditions
like epilepsy face myriad challenges including establishing and
following a treatment regimen, developing and enacting self-management
plans, and finding social support.
Compounding these challenges are the reactions and beliefs of
people with whom they interact. The stigma and perceived stigma of
their health condition can lead to problems with self-management of
their disease and further morbidity.
The goal of this project is to develop a valid and reliable
measurement tool to assess the public's perception of epilepsy and
seizure disorders. This tool may shed light on the challenges in the
social environment confronted by people with epilepsy and by their care
givers. It will help gauge the climate of the general public and guide
future epilepsy interventions. Once the tool has been developed,
reliability and validity tests need to be conducted to ensure it is a
scientifically rigorous instrument.
The goals of the proposed data collection are to assess the
instrument's:
Internal consistency--how well different measures of the
same construct reflect that construct
Concurrent validity--the degree to which an operation is
able to predict the behavior it purports to predict
Construct validity--the extent to which an operation
measures only the defined construct and not other constructs
Test-retest reliability--the stability of the measure over
time
A random digit dial survey will be conducted with 750 respondents
via computer assisted telephone interviewing (CATI) techniques. The
number of respondents is sufficient to be generalizable to the U.S.
population and to perform data reduction techniques such as factor
analysis. Of the 750 respondents, 100 will be called back within two
weeks to assess test-retest reliability. The total annual burden for
this data collection is 318 hours.
----------------------------------------------------------------------------------------------------------------
Number of Average burden/
Survey Number of responses/ response (in
respondents respondent hours)
----------------------------------------------------------------------------------------------------------------
Screening Calls................................................. 900 1 2/60
Completed Interviews............................................ 750 1 20/60
Reliability Test-Screening...................................... 120 1 2/60
Reliability Test-Completed Interviews........................... 100 1 20/60
----------------------------------------------------------------------------------------------------------------
Dated: June 6, 2002.
Julie Fishman,
Acting Associate Director for Policy, Planning and Evaluation, Centers
for Disease Control and Prevention.
[FR Doc. 02-15014 Filed 6-13-02; 8:45 am]
BILLING CODE 4163-18-P